Study on pathologic changes of hepatic fibrosis by telmisartan in experimental rats

李国云,孟丽萍,傅茂英,金凤,甘建和

DOI: https://doi.org/10.3969/j.issn.1672-5069.2011.03.005

2011-01-01

Abstract:Objective To investigate the effect of telmisartan on hepatic fibrosis induced by CCl4 in experimental rats.Methods Total 40 male SD rats were randomly divided into 3 groups,i.e,control(n=12),model(n=12)and telmisartan groups(n=16).The liver fibrotic model was induced by CCl4 and the liver pathological changes were observed.Results The liver index in model was 4.85±0.42,in control was 2.92±0.41 and in interventional group was 3.09±0.36(P<0.05);The HAI in model was 18.6±2.1,in normal was 0.0±0.0 and in telmisartan group was 8.6±1.9(P<0.01);the hepatic fibrosis scores in model was 14.5±1.6,in control was 0.33±0.49 and in telmisartan group was 7.7±1.7(P<0.01).Conclusions Telmisartan can improve the hepatic fibrosis in rats.